NCT01409733

TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Heidelberg University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The Aim is to evaluate safety and efficacy of TACE with doxorubicin-loaded DC beads in melanoma patients with liver metastasis. This is a pilot study with the aim of recruiting 20 patients, this is a feasibility study. the patients profile is patients with stage IV Melanoma with liver metastases.

Conditions

• Stage IV Melanoma Patients With Unresectable Liver Metastases

Interventions

Type	Name	Description
DEVICE	TACE using Drug Eluting Beads loaded with Doxorubicin	100-300 microns DC Beads loaded with Doxorubicin (75mg of Doxorubixcin per vial)

Timeline

• Start date: 2010-06-01
• Primary completion: 2012-09-01
• Completion: 2012-12-01
• First posted: 2011-08-04
• Last updated: 2011-08-04

Locations

1 site across 1 country: Germany